iTonic Holdings Ltd, a healthcare solution provider specializing in brachytherapy treatment planning systems, announced that Nasdaq approved their request for a 180-calendar day extension, until October 19, 2026, to comply with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company received notification on April 21, 2026, following the expiration of the initial compliance period on April 20, 2026.